silvadi, have proven to be much more effective, with cure rates well over 90% in three months of treatment or less. the cost of the cure is nearly $100,000 per patient >> it is very expensive. even if there is a cut rate discount, it is still very expensive. >> reporter: this man is her doctor. like most of his low-income patients at the john bell health center, her health care is covered by state-funded medicaid. >> we treat predominantly all inner-city, low-income, either insured through public assistance or uninsured patients. >> reporter: that means taxpayers and cash-strapped states are left to foot the bill. across the nation states have quietly thrown up roadblocks. it makes hepatitis c patients to get treatment. her application was rejected four times. >> denied completely because harrvone is not necessary because you do not meet the hepatitis c treatment. >> reporter: they're saying they won't pay for the miracle drug until her liver disease gets worse. her experience isn't uncommon. doctors find both private insurers and medicate frequently reject hepatitis c patients who are not